MLPA® - MRC Holland Kits
Please note before download:
- Mix descriptions are only free of charge for customers with maintenance contract.
- Don't hesitate to contact us, if there are any mix descriptions missing on this website.
-
To set up a new mix descriptions for you, still available at MRC Hollands website, please provide us the name of the mix (e.g. P002-D1), the version of the mix (e.g. Vs.02) and the date of its release.
- To set up a new mix descriptions for you, not available at MRC Hollands website any more, please provide us the corresponding document by email or fax (+49-7822-440150-20).
Download
- log into your SEQUENCE Pilot installation
- go to category MLPA®
- go to operation Mixes [master file]
- press button [Import] and select the downloaded mme-file
- if the corresponding mix already exists in your SEQUENE_PILOT installation you will be asked "Do you want to save the mix with a new name / lot?"; please press button [Yes] and complete the fields in the following dialogue; press button [OK] to save your entries
- if the mix doesn't exist yet just press button [OK] in the following dialogue
MIX
VERSION
DATE
REGION
APPLICATION
DOWNLOAD
MIX
P260-B1
VERSION
Vs. 07
DATE
29-02-2016
REGION
5q31, 16p12, 17q12, 17q22
APPLICATION
Fanconi Anemia
MIX
P260-C1
VERSION
Vs. C1-01
DATE
19-04-2018
REGION
5q31, 16p12, 17q12, 17q22
APPLICATION
Fanconi Anemia
MIX
P260-C1
VERSION
Vs. C1-02
DATE
27-04-2020
REGION
RAD50 5q31.1; PALB2 16p12.1; RAD51D 17q12; RAD51C 17q22
APPLICATION
Susceptibility to breast and ovarian cancer; Susceptibility to other cancer types; Fanconi-anemia type N
MIX
P260-C1
VERSION
Vs. C1-03
DATE
22-01-2021
REGION
RAD50 5q31.1; PALB2 16p12.1; RAD51D 17q12; RAD51C 17q22
APPLICATION
Susceptibility to breast and ovarian cancer; Susceptibility to other cancer types; Fanconi-anemia type N
MIX
P260-C1
VERSION
Vs. C1-04
DATE
06-04-2021
REGION
RAD50 5q31.1; PALB2 16p12.1; RAD51D 17q12; RAD51C 17q22
APPLICATION
Susceptibility to breast and ovarian cancer; Susceptibility to other cancer types; Fanconi-anemia type N
MIX
P260-C1
VERSION
Vs. C1-05
DATE
14-04-2022
REGION
RAD50 5q31.1; PALB2 16p12.1; RAD51D 17q12; RAD51C 17q22
APPLICATION
Susceptibility to breast and ovarian cancer; Susceptibility to other cancer types; Fanconi-anemia type N
MIX
P262-A2
VERSION
Vs. 08
DATE
24-03-2015
REGION
GHR 5p12, JAK2 9q24.1, IGF1 12q23, STAT5B 17q21
APPLICATION
Growth Hormone Insensitivity (GHI)
MIX
P262-B1
VERSION
Vs. 11
DATE
01-09-2017
REGION
GHR 5p12, JAK2 9q24.1, IGF1 12q23, STAT5B 17q21
APPLICATION
Growth Hormone Insensitivity (GHI)
MIX
P262-B2
VERSION
Vs. B2-01
DATE
23-06-2021
REGION
GHR 5p12-13.1; JAK2 9p24.1; IGF1 12q23.2; STAT5B 17q21.2
APPLICATION
Growth hormone insensitivity (GHI)
MIX
P264-B1
VERSION
Vs. 05
DATE
05-11-2011
REGION
1q, 2q, 3q, 4q
APPLICATION
Subtelomeric screening
MIX
P264-C1
VERSION
Vs. 10
DATE
08-03-2018
REGION
1q, 2q, 3q, 4q
APPLICATION
Subtelomeric screening
MIX
P265-B3
VERSION
Vs. 07
DATE
25-11-2016
REGION
PROC 2q14.3
APPLICATION
Protein C deficiency (PROC)
MIX
P265-B4
VERSION
Vs. B4-01
DATE
18-04-2019
REGION
PROC 2q14.3
APPLICATION
Protein C deficiency (PROC)
MIX
P265-B4
VERSION
Vs. B4-02
DATE
28-09-2022
REGION
PROC 2q14.3
APPLICATION
Protein C deficiency (PROC)
MIX
P266-B2
VERSION
Vs. B2-01
DATE
22-03-2018
REGION
CLCNKB 1p36
APPLICATION
Bartter syndrome
MIX
P266-B2
VERSION
Vs. B2-02
DATE
15-02-202
REGION
CLCNKB 1p36.13
APPLICATION
Bartter syndrome type 3
MIX
P267-A3
VERSION
Vs. 07
DATE
18-03-2014
REGION
ZIC1, ZIC4 3p2, VLDLR 9p24
APPLICATION
Dandy-Walker Malformation (DWM)
MIX
P267-B1
VERSION
Vs. B1-01
DATE
11-04-2018
REGION
ZIC1, ZIC4 3p2, VLDLR 9p24
APPLICATION
Dandy-Walker Malformation (DWM)
MIX
P268-A2
VERSION
Vs. 11
DATE
07-09-2017
REGION
DYSF 2p13.2
APPLICATION
Limb girdle muscular dystrophies type 2B (LGMD2B)
MIX
P268-A3
VERSION
Vs. A3-01
DATE
16-12-2019
REGION
DYSF 2p13.2
APPLICATION
Limb girdle muscular dystrophies type 2B (LGMD2B)
MIX
P269-B1
VERSION
Vs. 08
DATE
05-09-2014
REGION
Xq26 (NYS1 locus), FRMD7
APPLICATION
Congenital nystagmus
MIX
P269-B1
VERSION
Vs. B1-01
DATE
14-05-2018
REGION
Xq26 (NYS1 locus), FRMD7
APPLICATION
Congenital nystagmus
MIX
P271-B4
VERSION
Vs. 10
DATE
09-06-2016
REGION
COL1A1 17q21.3
APPLICATION
Osteogenesis imperfecta (OI)
MIX
P271-B5
VERSION
Vs. B5-01
DATE
17-03-2020
REGION
COL1A1 17q21.33
APPLICATION
Osteogenesis imperfecta (OI)
MIX
P272-B2
VERSION
Vs. 13
DATE
16-01-2015
REGION
COL1A2 7q21.3
APPLICATION
Osteogenesis imperfecta (OI)
MIX
P272-C1
VERSION
Vs. 14
DATE
14-10-2016
REGION
COL1A2 7q21.3
APPLICATION
Osteogenesis imperfecta (OI)
MIX
P272-C1
VERSION
Vs. C1-01
DATE
08-07-2020
REGION
COL1A2 7q21.3
APPLICATION
Osteogenesis imperfecta (OI)
MIX
P274-A3
VERSION
Vs. 07
DATE
03-08-2015
REGION
GLRB 4q32.1, GLRA1 5q33.1, SLC6A5 11p15.1
APPLICATION
Startle disease, Hyperekplexia
MIX
P274-A4
VERSION
Vs. 08
DATE
30-11-2016
REGION
GLRB 4q32.1, GLRA1 5q33.1, SLC6A5 11p15.1
APPLICATION
Startle disease, Hyperekplexia
MIX
P275-C2
VERSION
Vs. 08
DATE
29-10-2016
REGION
MAPT 17q21
APPLICATION
Alzheimer's disease, Pick's disease, frontotemporal dementia, cortico-basal degeneration, progressive supranuclear palsy
MIX
P275-C3
VERSION
Vs. 09
DATE
24-11-2017
REGION
MAPT 17q21
APPLICATION
Alzheimer's disease, Pick's disease, frontotemporal dementia, cortico-basal degeneration, progressive supranuclear palsy
MIX
P275-C4
VERSION
Vs. C4-01
DATE
05-07-2021
REGION
MAPT 17q21
APPLICATION
Alzheimer's disease, Pick's disease, frontotemporal dementia, cortico-basal degeneration, progressive supranuclear palsy
MIX
P277-B1
VERSION
Vs. 05
DATE
29-06-2011
REGION
5q, 6q, 7q, 8q
APPLICATION
Subtelomeric screening
MIX
P277-B2
VERSION
Vs. 09
DATE
20-01-2016
REGION
5q, 6q, 7q, 8q
APPLICATION
Subtelomeric screening
MIX
P278-C2
VERSION
Vs. 11
DATE
06-01-2017
REGION
PCCA 13q32
APPLICATION
Propionic acidemia
MIX
P278-D1
VERSION
Vs. D1-01
DATE
18-10-2018
REGION
PCCA 13q32
APPLICATION
Propionic acidemia
MIX
P279-B2
VERSION
Vs. 13
DATE
03-08-2015
REGION
CACNA1A
APPLICATION
Episodic ataxia 2, Familial hemiplegic migraine
MIX
P279-B3
VERSION
Vs. 14
DATE
28-09-2016
REGION
CACNA1A
APPLICATION
Episodic ataxia 2, Familial hemiplegic migraine
MIX
P279-C1
VERSION
Vs. C1-01
DATE
28-08-2020
REGION
CACNA1A 19p13.13
APPLICATION
Episodic ataxia type 2; Hemiplegic migraine type 1, familial (FHM1)